RayThera Stock
RayThera focuses on discovering and advancing new small molecule medicines that target immune‑related diseases, applying deep expertise in drug design to create treatments where current options are limited. Its scientific approach accelerates early discovery and development to bring safer, more effective therapies toward clinical testing and eventual patient use. The company positions its research to transform care for complex immunological conditions through innovative therapeutic solutions.
Sign up for SecondMarket® to view the market and buy or sell RayThera Stock
Buy + SellRayThera Funding
Sign up to gain insights into RayThera funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Financing Round | Date | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Series A | Apr 04, 2025 | 70.00M | ||
| Series A | Apr 04, 2025 | 20.00M | ||
| Series A | Apr 04, 2025 | 20.00M |
See RayThera Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into RayThera Stock Valuation + Share Prices
View real-time Tape D® data on RayThera stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
RayThera Management Team
-
Board Member
Michael Rome
-
Board Member
Carl L. Gordon
-
Co-Founder, CEO, Board Member
Quing Dong
-
Co-Founder, Chief Scientific Officer, Board Member
Gene Hung
RayThera Major Investors
-
OrbiMed Advisors
-
Foresite Capital
-
TTM Capital
Learn More About RayThera Stock
Buy RayThera Stock
01RayThera stock does not trade on public stock exchanges. RayThera stock is considered a private security and you need to be an accredited investor to trade shares. To invest in RayThera stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell RayThera Stock
02RayThera Stock does not trade on public stock exchanges. In order to sell RayThera shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
RayThera Stock Price
03RayThera does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view RayThera share price and other valuable private market data.
Read more about secondary market private company stock prices:
RayThera Stock Ticker Symbol
04There is no ticker symbol for RayThera stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell RayThera Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell RayThera stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in RayThera Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in RayThera stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
RayThera Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
RayThera IPO
08RayThera is a private company and has not had an IPO. There is currently no RayThera IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to RayThera IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell RayThera Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
